Broad anti-angiogenic activity
Assets acting on this target.
- Class
- PEGylated recombinant human endostatin (anti-angiogenic biologic; modality should be corrected from null to 'biologic/recombinant protein', not a small molecule)
- Pathway
- Tumor angiogenesis inhibition
- Notes
- original target text: Broad anti-angiogenic activity (endothelial cell proliferation; VEGF/bFGF signaling and integrin/heparan-sulfate proteoglycan binding), not a single discrete receptor target
Related mechanisms